These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2540515)

  • 21. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
    Prichard BN; Saul PA
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic effects of ACE inhibitors.
    Berne C
    J Intern Med Suppl; 1991; 735():119-25. PubMed ID: 2043220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of enalapril on clinical and metabolic characteristics in patients with non-insulin-dependent diabetes and arterial hypertension].
    Novikov VI; Miliagina IV
    Ter Arkh; 2000; 72(12):63-4. PubMed ID: 11201838
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B; Vajo Z; Dachman W
    Acta Physiol Hung; 1996; 84(4):361-7. PubMed ID: 9328608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitors of the conversion enzyme and glycoregulation].
    Richard JL; Ferrière M; Bringer J; Mirouze J
    Diabete Metab; 1990; 16(3):265-6. PubMed ID: 2210026
    [No Abstract]   [Full Text] [Related]  

  • 33. Antihypertensive therapy and blood lipids: ACE inhibitors.
    Agner E
    Scand J Clin Lab Invest Suppl; 1990; 199():55-9. PubMed ID: 2191418
    [No Abstract]   [Full Text] [Related]  

  • 34. Enalapril: a long-acting angiotensin-converting enzyme inhibitor.
    Borek M; Charlap S; Frishman W
    Pharmacotherapy; 1987; 7(5):133-48. PubMed ID: 2829141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin I converting enzyme inhibitors and the renal excretion of urate.
    Leary WP; Reyes AJ
    Cardiovasc Drugs Ther; 1987; 1(1):29-38. PubMed ID: 3154308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of antihypertensive treatment and good glycemic control on plasma lipids in diabetic rats.
    Reddi AS; Jyothirmayi GN; Bollineni JS
    J Diabetes Complications; 1995; 9(3):163-9. PubMed ID: 7548980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic treatment of hypertensive patients with converting enzyme inhibitors.
    Nussberger J; Biollaz J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S20-5. PubMed ID: 2422489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism.
    Shionoiri H; Sugimoto K; Minamisawa K; Ueda S; Ebina T; Matsukawa T; Gotoh E; Ishii M
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):933-8. PubMed ID: 1694916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A long-term comparison between enalapril and captopril on insulin sensitivity in normotensive non-insulin dependent diabetic volunteers.
    Tillmann HC; Walker RJ; Lewis-Barned NJ; Edwards EA; Robertson MC
    J Clin Pharm Ther; 1997 Aug; 22(4):273-8. PubMed ID: 9548208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.